Product Overview
The BIRMINGHAM HIPâ—Š Resurfacing (BHRâ—Š) System is a conservative approach to hip arthroplasty in which an all-metal bearing couple is used to preserve, rather than replace, a patient’s femoral head and neck. It was first implanted in July 1997, and was approved for use in the United States by the Food and Drug Administration in 2006. Since its introduction, there have been over 175,000 BHR implantations worldwide.
Features of the BHR include:
Less bone resection than conventional total hip arthroplasty
Availability of global, long-term clinical outcomes data
Functionally optimized metallurgy and design
This successful, bone conserving hip resurfacing system is well documented through independent clinical and laboratory studies. Additional clinical evidence supporting the BHR is published by national and regional arthroplasty registries. This bone conserving procedure, combined with an implant design intended to decrease the risk of dislocation and excellent survivorship, makes the BHR ideal for the younger, active male patient. For additional information, contact your local sales representative or e-mail BHR.Inquiries@smith-nephew.com.
Only physicians who have received appropriate training and are familiar with the implant components, instruments, procedure, clinical applications, adverse events, and risks associated with the BHR System should use this device. Contact Smith & Nephew Orthopaedics Ltd. for the surgical technique manual and procedural training protocol. (http://www.smith-nephew.com/)
